Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 41 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
26 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
UnifiedMed Group from Izegem, company number BE0794689128, closed financial year 2025 with a result of € 9,739 after tax. For that financial year UnifiedMed Group recorded a gross margin of € -17,810 and equity of € 714,038. Compared with financial year 2024, the result moved from € 179,035 to € 9,739. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.
€ 714,038
▲ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 9,739
▼ 95% vs 2024
Profit after tax over the fiscal year.
€ 643,471
▲ € 637,734 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 514,038.
People and assets in 2025
2.3
▲ 1.3 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 148,716
▲ 289% vs 2024
€ 64,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 75,594
Of which on lease € 75,594.
Debts at end 2025
€ 3.8 million
▼ 5% vs 2024
€ 299,847 is repaid this year. At this pace the long-term loan is gone in ≈ 13 years.
€ 119,318
▲ € 98,738 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 22,939
▲ € 17,962 vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € -163,580 | € -194,568 | € -17,810 | ▲ € 176,758 |
| Profit after taxes | € 325,264 | € 179,035 | € 9,739 | ▼ 95% |
| Equity | € 500,264 | € 704,299 | € 714,038 | ▲ 1% |
| Total debts | € 3,488,006 | € 4,929,162 | € 6,353,716 | ▲ 29% |
| Cash | € 73,140 | € 5,738 | € 643,471 | ▲ € 637,734 |
| Retained profit | € 325,264 | € 504,299 | € 514,038 | ▲ 2% |
| Bank debt | € 3,332,500 | € 3,976,300 | € 3,767,108 | ▼ 5% |
| Balance sheet total | € 3,988,270 | € 5,633,461 | € 7,067,754 | ▲ 25% |
| Employees (FTE) | - | 1 | 2.3 | ▲ 1.3 |
Key figures of UnifiedMed Group, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to UnifiedMed Group?
What happened at UnifiedMed Group in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Leapfuse BV stepped down as director. NBB
- De Langhe Frank stepped down as director. NBB
- Blervaque Sébastien stepped down as director. NBB
- Claikens Bart stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 9,739 (▼ 95% vs 2024). Source: NBB ↗
- Leapfuse BV became a director. NBB
- New establishment in Izegem. KBO
- De Langhe Frank became a director. NBB
In short
From € 325,264 profit in 2023 to € 9,739 profit in 2025.
Paid € 176 in corporate taxes since 2023.
Best year ever: 2023, with € 325,264 profit.
A new publication or filing at UnifiedMed Group? We notify you, reason included.
Follow UnifiedMed GroupDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
It owns 100% of MB Declerck, 100% of Radiologiepraktijken UMG and 100% of DR. HILDE DURANT itself.
Directors
According to the 2025 annual accounts
Persoon belast met dagelijks bestuur · represented by Sébastien Blervaque
since 2023 · until 2028
De Langhe Frank
Director
since 2022 · until 2028
Blervaque Sébastien
Director
since 2022 · until 2028
Claikens Bart
Director
since 2022 · until 2028
Establishments
Establishment units
Physical locations of this company
Ambachtenstraat 33
8870 Izegem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 26 companies are registered at this address.
All companies at this address →SKYLINE COMMUNICATIONS
€ 31.1 million revenue · 2025
FPS Flexibles Belgium
€ 829,861 gross margin · 2025
BSA Security
€ 75,833 gross margin · 2025
Turner
€ 396,563 gross margin · 2025
LIWECO
€ 374,186 gross margin · 2025
+21 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0794.689.128
- VAT number
- BE 0794.689.128
- Registered office
- Ambachtenstraat 33, 8870 Izegem
- Names & denominations
- UnifiedMed Group
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 13 December 2022
- Peppol
- Active · Active since 12 Feb 2026
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering